Apyx Medical
APYX
45 hedge funds and large institutions have $25.2M invested in Apyx Medical in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
59% more capital invested
Capital invested by funds: $15.9M → $25.2M (+$9.29M)
5.36% more ownership
Funds ownership: 36.95% → 42.31% (+5.4%)
0% more funds holding
Funds holding: 45 → 45 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 16
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $8K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.43M |
| 2 |
PA
Perceptive Advisors
New York
|
+$210K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$75.2K |
| 4 |
RA
Royce & Associates
New York
|
+$46K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$40.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Rathbones Group
Liverpool,
United Kingdom
|
-$210K |
| 2 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$154K |
| 3 |
TFCM
Taylor Frigon Capital Management
Scottsdale,
Arizona
|
-$71.5K |
| 4 |
GCA
Greenwood Capital Associates
Greenwood,
South Carolina
|
-$36.5K |
| 5 |
LWA
Ledgewood Wealth Advisors
Exeter,
New Hampshire
|
-$28K |
APYX Hedge Fund Activity: Q4 2024 in Review
45 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q4 2024, worth a combined $25.2M — up 59% from $15.9M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new APYX positions and 3 closed out — a net gain of 2 holders — while 12 added to existing stakes and 16 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $4.43M. The largest seller was Rathbones Group, cutting an estimated $210K.
- 45 institutional investors held Apyx Medical (APYX) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $25.2M of Apyx Medical stock for Q4 2024, up 59% quarter-over-quarter.
- 5 funds opened new Apyx Medical positions in Q4 2024 and 3 closed out, a net change of +2 holders.
- The largest Apyx Medical buyer in Q4 2024 was Nantahala Capital Management, an estimated $4.43M added.
- The largest Apyx Medical seller in Q4 2024 was Rathbones Group, an estimated $210K sold.
Based on aggregated 13F filings for Q4 2024.